Axsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock TD Cowen analyst Joseph Thome’s new price target represents a potential upside of about 23% from AXSM’s current trading levels.
Bitcoin Sale Is Not A ‘Concern,’ No Plans To Stop Mining, Says Bitdeer – BTDR Stock Slips Overnight Bitdeer said on Monday that it plans to keep mining Bitcoin and anticipates that its hash rate will continue to grow.
SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December.
ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries The company also announced the establishment of an Irish subsidiary in Dublin to support its distribution and commercialization strategy across Europe.
HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally The FDA has approved Harmony’s Wakix tablets for the treatment of cataplexy in pediatric patients aged 6 years and older with narcolepsy.
Why Is TRIP Stock Rallying Today? Starboard said that it believes that Tripadvisor should be formally exploring a sale of the entire company, in one or multiple transactions.
Wall Street Pauses for Presidents Day as Record-Breaking Dow Faces Tech Sector Headwinds NEW YORK — The floor of the New York Stock Exchange (
NYSE: ICE ) sits silent today, February 16, 2026, as the U.S. financial markets observe the Presidents Day holiday. While the closure provides a momentary reprieve for traders, the atmosphere remains charged with anticipation following a highly divergent week of
We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return Learn options trading inside a system that values evidence, structure, and defined risk. A real member explains the difference.
Blueshift Dumps 34,000 CROX Shares Worth $2.9 Million Crocs designs and markets casual footwear and accessories for a global customer base, leveraging both retail and e-commerce channels.
VOO Has Delivered Higher Returns, But IWM Provides Broad Small Cap Exposure Explore how IWM’s broader sector mix and unique small-cap focus set it apart from VOO’s concentrated large-cap approach.
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin.
NVCR Rallies On FDA Approval For Cancer Treatment Device, Analyst Still Sees 275% Potential Upside H.C. Wainwright raised the firm's price target on Novocure to $47 from $39 and kept a ‘Buy’ rating on the shares after the company announced FDA approval of Optune Pax.
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff Randy Teel has been appointed as President, CEO, as well as a member of the Company’s Board of Directors, effective immediately.
Upstart Stock Rallies 7% After-Hours Today — Who Is The New CEO? Upstart also reported total revenue of $296 million in its fourth quarter, a 35% jump from the year-ago quarter.
